JP2010539893A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010539893A5 JP2010539893A5 JP2010525273A JP2010525273A JP2010539893A5 JP 2010539893 A5 JP2010539893 A5 JP 2010539893A5 JP 2010525273 A JP2010525273 A JP 2010525273A JP 2010525273 A JP2010525273 A JP 2010525273A JP 2010539893 A5 JP2010539893 A5 JP 2010539893A5
- Authority
- JP
- Japan
- Prior art keywords
- stretch
- nucleic acid
- acid according
- nucleotides
- box
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07018750.5 | 2007-09-24 | ||
| EP07018750 | 2007-09-24 | ||
| PCT/EP2008/008097 WO2009040113A2 (en) | 2007-09-24 | 2008-09-24 | C5a BINDING NUCLEIC ACIDS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010539893A JP2010539893A (ja) | 2010-12-24 |
| JP2010539893A5 true JP2010539893A5 (https=) | 2011-11-04 |
| JP5798320B2 JP5798320B2 (ja) | 2015-10-21 |
Family
ID=40174751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525273A Expired - Fee Related JP5798320B2 (ja) | 2007-09-24 | 2008-09-24 | Ｃ５ａに結合する核酸 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8507456B2 (https=) |
| EP (2) | EP2205734A2 (https=) |
| JP (1) | JP5798320B2 (https=) |
| KR (1) | KR20100072185A (https=) |
| CN (1) | CN101809154A (https=) |
| AU (1) | AU2008303775A1 (https=) |
| BR (1) | BRPI0817260A2 (https=) |
| CA (1) | CA2700441A1 (https=) |
| MX (1) | MX2010003109A (https=) |
| RU (1) | RU2010116245A (https=) |
| WO (1) | WO2009040113A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
| WO2010108657A2 (en) * | 2009-03-23 | 2010-09-30 | Noxxon Pharma Ag | C5a binding nucleic acids and the use thereof |
| CN102597775A (zh) * | 2009-09-25 | 2012-07-18 | 佐马技术有限公司 | 筛选方法 |
| KR20140044324A (ko) * | 2011-04-26 | 2014-04-14 | 레가도 바이오사이언스, 인코포레이티드 | 페길화된 올리고뉴클레오티드의 제조방법 |
| EP2718866B1 (en) | 2011-06-07 | 2020-09-09 | Koninklijke Philips N.V. | Providing nucleotide sequence data |
| US10531655B2 (en) | 2011-12-02 | 2020-01-14 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
| WO2013104540A1 (en) * | 2012-01-10 | 2013-07-18 | Noxxon Pharma Ag | New c5a binding nucleic acids |
| WO2015066027A2 (en) | 2013-10-28 | 2015-05-07 | Dots Devices, Inc. | Allergen detection |
| WO2015103438A2 (en) | 2014-01-02 | 2015-07-09 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
| CN106860867A (zh) * | 2017-02-23 | 2017-06-20 | 中山大学 | 己糖激酶2特异性抑制剂在急性中枢神经系统损伤疾病中的应用 |
| EP3553521A1 (en) * | 2018-04-12 | 2019-10-16 | Koninklijke Philips N.V. | Gingivitis diagnostic methods, uses and kits |
| WO2025196240A1 (en) | 2024-03-20 | 2025-09-25 | Aptarion Biotech Ag | Method of treating a disorder with a c5a inhibitor |
| EP4620474A1 (en) | 2024-03-20 | 2025-09-24 | APTARION biotech AG | Method of treating a disorder with a c5a inhibitor |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| US6395888B1 (en) * | 1996-02-01 | 2002-05-28 | Gilead Sciences, Inc. | High affinity nucleic acid ligands of complement system proteins |
| US6395029B1 (en) | 1999-01-19 | 2002-05-28 | The Children's Hospital Of Philadelphia | Sustained delivery of polyionic bioactive agents |
| US6652886B2 (en) | 2001-02-16 | 2003-11-25 | Expression Genetics | Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents |
| EP1306382A1 (de) | 2001-10-26 | 2003-05-02 | Noxxon Pharma AG | Modifizierte L-Nukleinsäure |
| WO2003070823A2 (en) | 2002-02-20 | 2003-08-28 | The General Hospital Corporation | Conjugates comprising a biodegradable polymer and uses therefor |
| MXPA05011022A (es) | 2003-04-13 | 2006-04-27 | Enzon Pharmaceuticals Inc | Profarmacos oligonucleotidos polimericos. |
| GB0314472D0 (en) | 2003-06-20 | 2003-07-23 | Warwick Effect Polymers Ltd | Polymer |
| US20070116710A1 (en) * | 2004-02-03 | 2007-05-24 | Leonard Bell | Methods of treating hemolytic anemia |
| US20090281296A1 (en) | 2004-02-09 | 2009-11-12 | Supramol Parenteral Colloid Gmbh | Process for the production of conjugates from polysaccharides and polynucelotides |
| PL3385384T3 (pl) | 2004-02-12 | 2021-03-08 | Archemix Llc | Aptamerowe środki terapeutyczne użyteczne w leczeniu zaburzeń powiązanych z dopełniaczem |
| US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
| MXPA06010782A (es) | 2004-03-23 | 2007-03-28 | Complex Biosystems Gmbh | Ligador de profarmaco. |
| CN101098703B (zh) | 2004-11-05 | 2011-08-03 | 费城儿童医院 | 用于分子治疗的生物降解连接剂 |
| KR101584468B1 (ko) * | 2006-03-08 | 2016-01-13 | 아케믹스 엘엘씨 | 안질환의 치료에 유용한 보체 결합 앱타머 및 항-ｃ5 제제 |
| JP2010503707A (ja) | 2006-09-15 | 2010-02-04 | エンゾン ファーマスーティカルズ インコーポレイテッド | オリゴヌクレオチドの送達を目的としたヒンダードエステル系生体分解性リンカー |
| WO2008052774A2 (en) | 2006-10-31 | 2008-05-08 | Noxxon Pharma Ag | Methods for detection of a single- or double-stranded nucleic acid molecule |
| WO2010108657A2 (en) * | 2009-03-23 | 2010-09-30 | Noxxon Pharma Ag | C5a binding nucleic acids and the use thereof |
-
2008
- 2008-09-24 CA CA2700441A patent/CA2700441A1/en not_active Abandoned
- 2008-09-24 AU AU2008303775A patent/AU2008303775A1/en not_active Abandoned
- 2008-09-24 BR BRPI0817260-9A2A patent/BRPI0817260A2/pt not_active IP Right Cessation
- 2008-09-24 WO PCT/EP2008/008097 patent/WO2009040113A2/en not_active Ceased
- 2008-09-24 US US12/679,307 patent/US8507456B2/en not_active Expired - Fee Related
- 2008-09-24 MX MX2010003109A patent/MX2010003109A/es not_active Application Discontinuation
- 2008-09-24 CN CN200880108439A patent/CN101809154A/zh active Pending
- 2008-09-24 JP JP2010525273A patent/JP5798320B2/ja not_active Expired - Fee Related
- 2008-09-24 RU RU2010116245/10A patent/RU2010116245A/ru not_active Application Discontinuation
- 2008-09-24 EP EP08834443A patent/EP2205734A2/en not_active Withdrawn
- 2008-09-24 EP EP12006735.0A patent/EP2562256A3/en not_active Withdrawn
- 2008-09-24 KR KR1020107005454A patent/KR20100072185A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010539893A5 (https=) | ||
| RU2010116245A (ru) | НУКЛЕИНОВЫЕ КИСЛОТЫ, СВЯЗЫВАЮЩИЕ C5a | |
| US12070458B2 (en) | Therapeutic agent composition and method of use, for treatment of mild congnitive impairment, depression, and psychological disorders | |
| Gombert et al. | Outcome of elective and emergency open thoraco-abdominal aortic aneurysm repair in 255 cases: a retrospective single centre study | |
| CA2663072C (en) | Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field | |
| TW201134482A (en) | Aptamers to β -NGF and their use in treating β -NGF mediated diseases and disorders | |
| JP2010504083A5 (https=) | ||
| US11565002B2 (en) | Thrombus imaging aptamers and methods of using same | |
| JP6640725B2 (ja) | ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す | |
| Muchtar et al. | Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines | |
| US20150335612A1 (en) | Artemisinin And Its Derivatives For Use In The Treatment Of Kidney Disease | |
| CN103805563B (zh) | 一种脑靶向干细胞及其制备方法和应用 | |
| WO2019006692A1 (zh) | 用于治疗、改善或预防神经系统相关病症的化合物及其用途 | |
| CN112121042A (zh) | Pso用于制备抗败血症及其诱发的心肌损伤药物的应用 | |
| CN119390854A (zh) | 一种多肽Tat-CIRP及其应用 | |
| WO2017147044A1 (en) | Peptides and methods for treatment of neurodegenerative diseases | |
| ES2546094T3 (es) | Antagonistas contra la interacción de PF4 y RANTES | |
| Kar et al. | Anesthesia management of renal transplantation: an update | |
| US20250177479A1 (en) | Depsipeptide-based amphiphilic buliding block to inhibit protein-protein interactions, nanostructure comprised thereof and uses thereof | |
| EP4522191A1 (en) | Agents inducing vascularisation | |
| Bozan et al. | The diagnostic efficacy of some ischemic markers (urotensin II and urotensin II related peptide) in early diagnosis of intestinal ischemia in experimentally increased intraabdominal pressure in rats | |
| WO2026056035A1 (zh) | 一种具有神经保护功能的含脒基新型iNOS抑制剂及其制备方法与应用 | |
| JP4582561B2 (ja) | 移植による血管病変の発生抑制剤 | |
| Shi et al. | Development of Oxytocin-and Vasopressin-Network in the Supraoptic and Paraventricular Nuclei of Fetal Sheep | |
| CN121868277A (zh) | Slco5a1在制备用于治疗和/或预防心力衰竭药物中的应用 |